Barclays

Barclays initiated coverage of the U.S. small- and mid-cap biotechnology industry with a Positive view, as it expects the outperformance of the sector relative to the S&P 500 to continue in the next 12-18 months. The firm's positive opinion was premised on three factors, namely phase 3...

z,pz.Even as Barclays initiated coverage of the U.S. small- and mid-cap biotechnology industry with a positive view, it was bearish on Cascadian Therapeutics Inc (USA) (NASDAQ: CASC) and Zymeworks Inc (NYSE: ZYME). The firm initiated coverage of Cascadian Therapeutics with an Underweight rating...

There’s no question that CBS Corporation (NYSE: CBS) took in plenty of revenue from its live Showtime broadcast of the Floyd Mayweather/Conor McGregor fight on Aug. 26. However, a new report from Barclays analyst Kannan Venkateshwar suggests CBS could have made even more money than it did....

Barclays initiated coverage of Baker Hughes, a GE company Class A (NYSE: BHGE), with an Overweight rating and a $41 price target. The firm believes the company will be given some early leeway to justify a multiple relatively in line with Halliburton Company (NYSE: HAL) and Schlumberger...

Ahead of Best Buy Co Inc (NYSE: BBY)'s second-quarter earnings report set for Tuesday, Barclays is increasing its estimates on the quarter as well as estimates for fiscal year 2018 and 2019. Flirting with new 52-week highs last week, Best Buy historically has taken share amid the ongoing industry...

Boasting sales growth and margin improvement, Canada Goose Holdings Inc. Subordinate Voting Shares (NYSE: GOOS) outperformed Street estimates this quarter. But the beats didn’t do much good. The stock opened up 6.4 percent on Goose’s Thursday morning earnings report but promptly slid 8....

Snap Inc (NYSE: SNAP) shared plummeted 11 percent Friday to new all-time lows following a disappointing Q2 earnings report. A number of Wall Street analysts weighed in on Snap on Friday. Here’s a rundown of what they had to say. Voices From The Street UBS analyst Eric Sheridan said another...

Reviewing NVIDIA Corporation (NASDAQ: NVDA)'s second-quarter results, Barclays probed beyond the shiny surface of the company's beat-and-raise quarter. Nvidia shares were down 4.15 percent to $157.91 at time of writing. Barclays has an Equal-Weight rating on the shares of Nvidia and a $...

Analysts from Baird and Barclays have a positive outlook for the Canada Goose Holdings Inc. Subordinate Voting Shares (NYSE: GOOS) first-quarter earnings report when it lands Thursday morning. Q1 represents only 3 to 4 percent of Canada Goose’s annual sales, Baird analyst Jonathan Komp said...

Foot Locker Inc. (NYSE: FL)'s recent woes may provide a good buying opportunity at current depressed levels. Last week, Barclays noted that if the company were to never grow again, it still would be worth more than its trading at. Morgan Stanley analyst Jay Sole, sees an excellent opportunity to...

While the retail footwear industry has experienced some tough times given major brands increased focus in e-commerce and direct to consumer sales, if Foot Locker, Inc. (NYSE: FL) were to never grow again, Barclays believes it's still under valued. “In a scenario where Foot Locker does not...

Shares of Illumina, Inc. (NASDAQ: ILMN) hit a new 52-week high of $198.47 Wednesday and ended the day higher by nearly 15 percent after the company reported top- and bottom-line beats in its second-quarter earnings report. However, the results weren't good enough for analysts at Barclays who are...

Blue Apron Holdings Inc (NYSE: APRN) shares jumped 13 percent on Monday after a number of its IPO underwriters weighed in on the stock for the first time following the expiration of the mandatory post-IPO quiet period. Here’s a rundown of what Wall Street had to say about Blue Apron. Barclays...

Previewing the results of casinos, Barclays said the second-quarter was overall a good one for gaming companies. The firm said strength in Macau, solid results in Las Vegas and continued stability in regional gaming provided a solid backdrop for companies in its coverage universe. Analyst...

Amid a slew of sell-side coverage initiations on Blue Apron Holdings Inc (NYSE: APRN) Monday morning, Barclays’ Ross Sandler was one of only three analysts’ to rate the company at Equal Weight. Sandler placed a $7 price target on the stock, which had climbed over 18 percent to $7.74 by...